Jonathan Chou is a Member of the Board of Directors of the Emerging Markets Investors Alliance.

Jonathan H. Chou is a seasoned finance executive and advisor with over 30 years of experience spanning international banking, Fortune 500 companies, and U.S.-listed firms in Asia. He has held CFO roles at UTAC Holdings Ltd. and Kulicke & Soffa Industries (Nasdaq:KLIC), where he played a key role in driving financial and operational success.

Jonathan began his career at Citibank before transitioning to senior finance leadership roles at various Fortune 500 companies. He currently serves on the Board of Directors of both MicroPort Scientific and MicroPort CardioFlow Medtech, global medical device companies listed on the Hong Kong Stock Exchange, where he chairs the Audit Committees.

Passionate about sustainable investment and governance, Jonathan was elected Chairman of the Board of the Emerging Markets Investors Alliance, effective January 2025. Since 2013, he has also served on the Fuqua School of Business’s East Asia Advisory Board at Duke University.

Jonathan holds a B.A. in Economics from the University at Buffalo and an MBA from Duke University’s Fuqua School of Business. He and his wife split their time between the U.S. and Singapore.